{"changeSha256":"622f6ae746b316f192d42186a1b0dd48438906114e35ae34474e56dd4b46bbb3","changedAt":"2026-09-15","changedFields":[{"after":"dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9","before":"dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8","field":"Cited source records"},{"after":"U.S. National Library of Medicine [sources: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9]","before":"U.S. National Library of Medicine [sources: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8]","field":"Named organizations"},{"after":"name: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9; aliases: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9; category: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9; status: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9; summary: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9; evidenceNote: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9","before":"name: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8; aliases: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8; category: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8; status: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8; summary: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8; evidenceNote: dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v8","field":"Claim citations"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/tesamorelin/versions/3/","version":3},"id":"profile:tesamorelin:v3","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"corrected","notice":"We refreshed this profile's label citation to the reviewed SPL version 9, published 2026-07-31. Earlier profile versions retain their original label citations. The product-specific label account identifies its reviewed scope.","peptideSlugs":["tesamorelin"],"previousChangeEvent":{"path":"/corrections/v1/profiles/tesamorelin/v2.json","sha256":"8188929056245b18649e0160c9310a0d8dc54ab225136c216cfb5e06cfde1dd1"},"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/tesamorelin/versions/2/","version":2},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-tesamorelin-3d783378-b02d-4f19-99dd-0fc91a042224-v9","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"EGRIFTA SV (tesamorelin) kit · SPL version 9 · published 2026-07-31","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=3d783378-b02d-4f19-99dd-0fc91a042224&version=9","verifiedAt":"2026-09-15"}],"subject":{"slug":"tesamorelin","type":"profile"}}